[1] | |
[2] |
ARDESTANI A, LUPSE B, MAEDLER K. Hippo signaling: key emerging pathway in cellular and whole-body metabolism[J]. Trends Endocrinol Metab, 2018, 29: 492-509. DOI:10.1016/j.tem.2018.04.006 |
[3] | |
[4] |
VARELAS X. The Hippo pathway effectors Taz and Yap in development, homeostasis and disease[J]. Development, 2014, 141: 1614-1626. DOI:10.1242/dev.102376 |
[5] |
MO J S, PARK H W, GUAN K L. The Hippo signaling pathway in stem cell biology and cancer[J]. EMBO Rep, 2014, 15: 642-656. DOI:10.15252/embr.201438638 |
[6] |
ZHU G, WANG Y, MIJITI M, WANG Z, WU P F, JIAFU D. Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway[J]. Biochem Biophys Res Commun, 2015, 465: 194-199. DOI:10.1016/j.bbrc.2015.07.149 |
[7] |
CHEN Y A, LU C Y, CHENG T Y, PAN S H, CHEN H F, CHANG N S. WW domain-containing proteins YAP and TAZ in the Hippo pathway as key regulators in stemness maintenance, tissue homeostasis, and tumorigenesis[J/OL]. Front Oncol, 2019, 9: 60. DOI: 10.3389/fonc.2019.00060.
|
[8] |
ZHANG Q, GUO Y, YU H, TANG Y, YUAN Y, JIANG Y, et al. Receptor activity-modifying protein 1 regulates the phenotypic expression of BMSCs via the Hippo/Yap pathway[J]. J Cell Physiol, 2019, 234: 13969-13976. DOI:10.1002/jcp.28082 |
[9] |
STANLEY A, HEO S J, MAUCK R L, MOURKIOTI F, SHORE E M. Elevated BMP and mechanical signaling through YAP1/Rhoa poises FOP mesenchymal progenitors for osteogenesis[J]. J Bone Miner Res, 2019, 34: 1894-1909. DOI:10.1002/jbmr.3760 |
[10] |
WANG B, LIN J, ZHANG Q, ZHANG X, YU H, GONG P, et al. αCGRP affects BMSCs' migration and osteogenesis via the Hippo-YAP pathway[J]. Cell Transplant, 2019, 28: 1420-1431. DOI:10.1177/0963689719871000 |
[11] |
YANG B, SUN H, CHEN P, FAN N, ZHONG H, LIU X, et al. Yap1 influences differentiation of osteoblastic MC3T3-E1 cells through the regulation of ID1[J]. J Cell Physiol, 2019, 234: 14007-14018. DOI:10.1002/jcp.28088 |
[12] |
KEGELMAN C D, MASON D E, DAWAHARE J H, HORAN D J, VIGIL G D, HOWARD S S, et al. Skeletal cell yap and taz combinatorially promote bone development[J]. FASEB J, 2018, 32: 2706-2721. DOI:10.1096/fj.201700872R |
[13] |
KEGELMAN C D, COULOMBE J C, JORDAN K M, HORAN D J, QIN L, ROBLING A G, et al. YAP and TAZ mediate osteocyte perilacunar/canalicular remodeling[J]. J Bone Miner Res, 2020, 35: 196-210. DOI:10.1002/jbmr.3876 |
[14] |
BRANDÃO A S, BENSIMON-BRITO A, LOURENÇO R, BORBINHA J, SOARES A R, MATEUS R, et al. Yap induces osteoblast differentiation by modulating bmp signalling during zebrafish caudal fin regeneration[J/OL]. J Cell Sci, 2019, 132: jcs231993. DOI: 10.1242/jcs.231993.
|
[15] |
LI C, WANG S, XING Z, LIN A, LIANG K, SONG J, et al. A ROR1-HER3-lncRNA signalling axis modulates the Hippo-Yap pathway to regulate bone metastasis[J]. Nat Cell Biol, 2017, 19: 106-119. DOI:10.1038/ncb3464 |
[16] |
ZHAO L, GUAN H, SONG C, WANG Y, LIU C, CAI C, et al. YAP1 is essential for osteoclastogenesis through a TEADs-dependent mechanism[J]. Bone, 2018, 110: 177-186. DOI:10.1016/j.bone.2018.01.035 |
[17] |
YANG W, HAN W, QIN A, WANG Z, XU J, QIAN Y. The emerging role of Hippo signaling pathway in regulating osteoclast formation[J]. J Cell Physiol, 2018, 233: 4606-4617. DOI:10.1002/jcp.26372 |
[18] |
XIONG J, ALMEIDA M, O'BRIEN C A. The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation[J]. Bone, 2018, 112: 1-9. DOI:10.1016/j.bone.2018.04.001 |
[19] | |
[20] |
AKIYAMA H, CHABOISSIER M C, MARTIN J F, SCHEDL A, DE CROMBRUGGHE B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6[J]. Genes Dev, 2002, 16: 2813-2828. DOI:10.1101/gad.1017802 |
[21] |
HATTORI T, MÜLLER C, GEBHARD S, BAUER E, PAUSCH F, SCHLUND B, et al. Sox9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification[J]. Development, 2010, 137: 901-911. DOI:10.1242/dev.045203 |
[22] |
GOTO H, NISHIO M, TO Y, OISHI T, MIYACHI Y, MAEHAMA T, et al. Loss of Mob1a/b in mice results in chondrodysplasia due to YAP1/TAZ-TEAD-dependent repression of SOX9[J/OL]. Development, 2018, 145: dev159244. DOI: 10.1242/dev.159244.
|
[23] |
YANG B, SUN H, SONG F, YU M, WU Y, WANG J. YAP1 negatively regulates chondrocyte differentiation partly by activating the β-catenin signaling pathway[J]. Int J Biochem Cell Biol, 2017, 87: 104-113. DOI:10.1016/j.biocel.2017.04.007 |
[24] |
AKIYAMA H, LYONS J P, MORI-AKIYAMA Y, YANG X, ZHANG R, ZHANG Z, et al. Interactions between Sox9 and β-catenin control chondrocyte differentiation[J]. Genes Dev, 2004, 18: 1072-1087. DOI:10.1101/gad.1171104 |
[25] |
DENG Y, WU A, LI P, LI G, QIN L, SONG H, et al. Yap1 regulates multiple steps of chondrocyte differentiation during skeletal development and bone repair[J]. Cell Rep, 2016, 14: 2224-2237. DOI:10.1016/j.celrep.2016.02.021 |
[26] |
YING J, WANG P, ZHANG S, XU T, ZHANG L, DONG R, et al. Transforming growth factor-beta1 promotes articular cartilage repair through canonical Smad and Hippo pathways in bone mesenchymal stem cells[J]. Life Sci, 2018, 192: 84-90. DOI:10.1016/j.lfs.2017.11.028 |
[27] | |
[28] |
CHENG J, JING Y, KANG D, YANG L, LI J, YU Z, et al. The role of Mst1 in lymphocyte homeostasis and function[J/OL]. Front Immunol, 2018, 9: 149. DOI: 10.3389/fimmu.2018.00149.
|
[29] |
DU X, YU A, TAO W. The non-canonical Hippo/Mst pathway in lymphocyte development and functions[J]. Acta Biochim Biophys Sin (Shanghai), 2015, 47: 60-64. DOI:10.1093/abbs/gmu112 |
[30] |
YANG B, SUN H, XU X, ZHONG H, WU Y, WANG J. YAP1 inhibits the induction of TNF- α-stimulated bone-resorbing mediators by suppressing the NF-κB signaling pathway in MC3T3-E1 cells[J]. J Cell Physiol, 2020, 235: 4698-4708. DOI:10.1002/jcp.29348 |
[31] | |
[32] |
DUPONT S, MORSUT L, ARAGONA M, ENZO E, GIULITTI S, CORDENONSI M, et al. Role of YAP/TAZ in mechanotransduction[J]. Nature, 2011, 474: 179-183. DOI:10.1038/nature10137 |
[33] |
WANG Y, HU G, LIU F, WANG X, WU M, SCHWARZ J J, et al. Deletion of yes-associated protein (YAP) specifically in cardiac and vascular smooth muscle cells reveals a crucial role for YAP in mouse cardiovascular development[J]. Circ Res, 2014, 114: 957-965. DOI:10.1161/CIRCRESAHA.114.303411 |
[34] |
VON GISE A, LIN Z, SCHLEGELMILCH K, HONOR L B, PAN G M, BUCK J N, et al. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy[J]. Proc Natl Acad Sci USA, 2012, 109: 2394-2399. DOI:10.1073/pnas.1116136109 |
[35] |
UEMURA M, NAGASAWA A, TERAI K. Yap/Taz transcriptional activity in endothelial cells promotes intramembranous ossification via the BMP pathway[J/OL]. Sci Rep, 2016, 6: 27473. DOI: 10.1038/srep27473.
|
[36] |
SIVARAJ K K, DHARMALINGAM B, MOHANAKRISHNAN V, JEONG H W, KATO K, SCHRÖDER S, et al. YAP1 and TAZ negatively control bone angiogenesis by limiting hypoxia-inducible factor signaling in endothelial cells[J/OL]. Elife, 2020, 9: e50770. DOI: 10.7554/eLife.50770.
|